EntryPoint Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
EntryPoint Capital's NVS Position: Q2 2026 in Review
EntryPoint Capital opened a new position in Novartis (NVS) in Q2 2026: 1,936 shares worth $303K. The stake represents 0.07% of the portfolio and ranks #549 among its holdings. This is a return to the name: EntryPoint Capital previously reported a position in NVS as recently as Q1 2024.
EntryPoint Capital first reported a position in NVS in Q4 2023 and has held it in 3 quarters since. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- EntryPoint Capital held 1,936 shares of Novartis worth $303K as of Q2 2026.
- Novartis was a new EntryPoint Capital position in Q2 2026.
- Novartis made up 0.07% of EntryPoint Capital's portfolio in Q2 2026, its #549 holding.
- EntryPoint Capital first reported a position in Novartis in Q4 2023 and has held it in 3 quarters since.
- 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.